DeltaTrak的全新疫苗供应链解决方案满足COVID-19疫苗存储、处理和运输所需的所有三种温度管理要求

2020-12-16 国际文传 国际文传

DeltaTrak®宣布了定制的疫苗温度监控解决方案,能满足COVID-19疫苗运输、存储和处理所需的三种温度要求。

DeltaTrak®宣布了定制的疫苗温度监控解决方案,能满足COVID-19疫苗运输、存储和处理所需的三种温度要求。它包括经过认证的警报温度计、数字数据记录仪(DDL)和实时监控器(RTL),以用于监测存储在冰箱、冰柜、超低温(ULT)冰柜和移动冰柜中的疫苗。这些解决方案是专门为缓解全球冷链运输挑战而设计的。

DeltaTrak总裁兼首席执行官Frederick Wu表示:“我们的疫苗监控解决方案符合要求的温度条件,对于确保疫苗功效能发挥关键作用。我们基于云的冷链供应网络可提供跟踪温度完整性的可视性,这对于分发COVID-19疫苗的利益相关者的成功至关重要。”

DeltaTrak的三合一疫苗监控器适用于需要定制温度管理范围的所有类型的疫苗:阿斯利康(2-8°C)、莫德纳(-20°C)和辉瑞(-70°C)。客户可以选择各种产品认证以最适合其运营需求或要求,这些认证包括:ISO 17025认证、NIST认证、WHO预认证、CDC和21 CFR Part 11兼容解决方案。实时监控器可选择将数据7天24小时全天候上传到FlashTrak云平台,使利益相关者能够接收警报并实时共享信息,以了解运输、存储和分发过程中的温度波动。

FlashTrak RTL供应链仪表板可增强数据可见性,以获取报告并与医院、诊所、药房、3PL或卫生部门等其他方共享。用户还可以使用该平台的地理围栏和API集成来对货物安全、温度警报、位置以及到达和离开状态进行自定义设置。云中的可操作数据所提供的可视性可帮助立即做出冷链管理决策,以采取纠正措施来保护用于挽救生命的COVID-19疫苗。

DeltaTrak的三合一疫苗监控解决方案目前可向美国和国际客户供应。

关于DeltaTrak®

DeltaTrak®是冷链完整性、环境监测和食品安全解决方案的领先创新者。可通过电话1-800-962-6776或电子邮件marketing@deltatrak.com联系DeltaTrak®。如需了解更多信息,请访问www.deltatrak.com

原文查阅:http://www.businesswirechina.com/zh/news/45302.html

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1657389, encodeId=ce73165e389ed, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Mon Nov 29 09:46:50 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975604, encodeId=feef9e56043d, content=话题, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210621/63f11e7c9993487f87168975d59885d7/bb210ee9bc0940eb806cb237495a7430.jpg, createdBy=91575377355, createdName=Conan888, createdTime=Mon Jun 21 22:36:51 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947497, encodeId=34fe194e49767, content=<a href='/topic/show?id=c11f29e67e' target=_blank style='color:#2F92EE;'>#ATRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2976, encryptionId=c11f29e67e, topicName=ATRA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XhttJCp4Aq9gKA5n4v9elclQlVQTDenMiaEiadlI5D3gtmfSiaicoIY4ZsuibrQKLibDdxBKVY8oS6B2FicqJlT93clow/132, createdBy=03202500144, createdName=ms7258648636991762, createdTime=Fri Jan 01 23:46:50 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988036, encodeId=bfa81988036a2, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Sun Apr 11 02:46:50 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693235, encodeId=d8fa16932357e, content=<a href='/topic/show?id=523b585602f' target=_blank style='color:#2F92EE;'>#新疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58560, encryptionId=523b585602f, topicName=新疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e8329353204, createdName=gous, createdTime=Fri May 14 05:46:50 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908596, encodeId=c53f90859626, content=满足COVID-19疫苗运输、存储和处理所需的三种温度要求。目前看来这是个好消息。, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5008534db22c474a844fbd107ff83af2/d3e20fc133b542208ff15e7f2b575329.jpg, createdBy=c7015311102, createdName=Jessie Zhang, createdTime=Wed Dec 16 16:03:15 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908326, encodeId=6c4f908326ee, content=棒棒哒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46085442053, createdName=ms6000000716169829, createdTime=Tue Dec 15 22:00:50 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908303, encodeId=3988908303e9, content= 评论中加<a href='/topic/show?id=979f91e9623' target=_blank style='color:#2F92EE;'>#话题#</a>,可以多加<a href='/topic/show?id=4365e5104f1' target=_blank style='color:#2F92EE;'>#积分#</a>哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91796, encryptionId=979f91e9623, topicName=话题), TopicDto(id=75104, encryptionId=4365e5104f1, topicName=积分)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Tue Dec 15 21:23:01 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
    2021-11-29 bsmagic9140
  2. [GetPortalCommentsPageByObjectIdResponse(id=1657389, encodeId=ce73165e389ed, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Mon Nov 29 09:46:50 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975604, encodeId=feef9e56043d, content=话题, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210621/63f11e7c9993487f87168975d59885d7/bb210ee9bc0940eb806cb237495a7430.jpg, createdBy=91575377355, createdName=Conan888, createdTime=Mon Jun 21 22:36:51 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947497, encodeId=34fe194e49767, content=<a href='/topic/show?id=c11f29e67e' target=_blank style='color:#2F92EE;'>#ATRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2976, encryptionId=c11f29e67e, topicName=ATRA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XhttJCp4Aq9gKA5n4v9elclQlVQTDenMiaEiadlI5D3gtmfSiaicoIY4ZsuibrQKLibDdxBKVY8oS6B2FicqJlT93clow/132, createdBy=03202500144, createdName=ms7258648636991762, createdTime=Fri Jan 01 23:46:50 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988036, encodeId=bfa81988036a2, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Sun Apr 11 02:46:50 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693235, encodeId=d8fa16932357e, content=<a href='/topic/show?id=523b585602f' target=_blank style='color:#2F92EE;'>#新疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58560, encryptionId=523b585602f, topicName=新疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e8329353204, createdName=gous, createdTime=Fri May 14 05:46:50 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908596, encodeId=c53f90859626, content=满足COVID-19疫苗运输、存储和处理所需的三种温度要求。目前看来这是个好消息。, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5008534db22c474a844fbd107ff83af2/d3e20fc133b542208ff15e7f2b575329.jpg, createdBy=c7015311102, createdName=Jessie Zhang, createdTime=Wed Dec 16 16:03:15 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908326, encodeId=6c4f908326ee, content=棒棒哒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46085442053, createdName=ms6000000716169829, createdTime=Tue Dec 15 22:00:50 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908303, encodeId=3988908303e9, content= 评论中加<a href='/topic/show?id=979f91e9623' target=_blank style='color:#2F92EE;'>#话题#</a>,可以多加<a href='/topic/show?id=4365e5104f1' target=_blank style='color:#2F92EE;'>#积分#</a>哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91796, encryptionId=979f91e9623, topicName=话题), TopicDto(id=75104, encryptionId=4365e5104f1, topicName=积分)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Tue Dec 15 21:23:01 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
    2021-06-21 Conan888

    话题

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1657389, encodeId=ce73165e389ed, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Mon Nov 29 09:46:50 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975604, encodeId=feef9e56043d, content=话题, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210621/63f11e7c9993487f87168975d59885d7/bb210ee9bc0940eb806cb237495a7430.jpg, createdBy=91575377355, createdName=Conan888, createdTime=Mon Jun 21 22:36:51 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947497, encodeId=34fe194e49767, content=<a href='/topic/show?id=c11f29e67e' target=_blank style='color:#2F92EE;'>#ATRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2976, encryptionId=c11f29e67e, topicName=ATRA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XhttJCp4Aq9gKA5n4v9elclQlVQTDenMiaEiadlI5D3gtmfSiaicoIY4ZsuibrQKLibDdxBKVY8oS6B2FicqJlT93clow/132, createdBy=03202500144, createdName=ms7258648636991762, createdTime=Fri Jan 01 23:46:50 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988036, encodeId=bfa81988036a2, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Sun Apr 11 02:46:50 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693235, encodeId=d8fa16932357e, content=<a href='/topic/show?id=523b585602f' target=_blank style='color:#2F92EE;'>#新疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58560, encryptionId=523b585602f, topicName=新疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e8329353204, createdName=gous, createdTime=Fri May 14 05:46:50 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908596, encodeId=c53f90859626, content=满足COVID-19疫苗运输、存储和处理所需的三种温度要求。目前看来这是个好消息。, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5008534db22c474a844fbd107ff83af2/d3e20fc133b542208ff15e7f2b575329.jpg, createdBy=c7015311102, createdName=Jessie Zhang, createdTime=Wed Dec 16 16:03:15 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908326, encodeId=6c4f908326ee, content=棒棒哒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46085442053, createdName=ms6000000716169829, createdTime=Tue Dec 15 22:00:50 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908303, encodeId=3988908303e9, content= 评论中加<a href='/topic/show?id=979f91e9623' target=_blank style='color:#2F92EE;'>#话题#</a>,可以多加<a href='/topic/show?id=4365e5104f1' target=_blank style='color:#2F92EE;'>#积分#</a>哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91796, encryptionId=979f91e9623, topicName=话题), TopicDto(id=75104, encryptionId=4365e5104f1, topicName=积分)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Tue Dec 15 21:23:01 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1657389, encodeId=ce73165e389ed, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Mon Nov 29 09:46:50 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975604, encodeId=feef9e56043d, content=话题, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210621/63f11e7c9993487f87168975d59885d7/bb210ee9bc0940eb806cb237495a7430.jpg, createdBy=91575377355, createdName=Conan888, createdTime=Mon Jun 21 22:36:51 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947497, encodeId=34fe194e49767, content=<a href='/topic/show?id=c11f29e67e' target=_blank style='color:#2F92EE;'>#ATRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2976, encryptionId=c11f29e67e, topicName=ATRA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XhttJCp4Aq9gKA5n4v9elclQlVQTDenMiaEiadlI5D3gtmfSiaicoIY4ZsuibrQKLibDdxBKVY8oS6B2FicqJlT93clow/132, createdBy=03202500144, createdName=ms7258648636991762, createdTime=Fri Jan 01 23:46:50 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988036, encodeId=bfa81988036a2, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Sun Apr 11 02:46:50 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693235, encodeId=d8fa16932357e, content=<a href='/topic/show?id=523b585602f' target=_blank style='color:#2F92EE;'>#新疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58560, encryptionId=523b585602f, topicName=新疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e8329353204, createdName=gous, createdTime=Fri May 14 05:46:50 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908596, encodeId=c53f90859626, content=满足COVID-19疫苗运输、存储和处理所需的三种温度要求。目前看来这是个好消息。, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5008534db22c474a844fbd107ff83af2/d3e20fc133b542208ff15e7f2b575329.jpg, createdBy=c7015311102, createdName=Jessie Zhang, createdTime=Wed Dec 16 16:03:15 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908326, encodeId=6c4f908326ee, content=棒棒哒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46085442053, createdName=ms6000000716169829, createdTime=Tue Dec 15 22:00:50 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908303, encodeId=3988908303e9, content= 评论中加<a href='/topic/show?id=979f91e9623' target=_blank style='color:#2F92EE;'>#话题#</a>,可以多加<a href='/topic/show?id=4365e5104f1' target=_blank style='color:#2F92EE;'>#积分#</a>哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91796, encryptionId=979f91e9623, topicName=话题), TopicDto(id=75104, encryptionId=4365e5104f1, topicName=积分)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Tue Dec 15 21:23:01 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1657389, encodeId=ce73165e389ed, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Mon Nov 29 09:46:50 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975604, encodeId=feef9e56043d, content=话题, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210621/63f11e7c9993487f87168975d59885d7/bb210ee9bc0940eb806cb237495a7430.jpg, createdBy=91575377355, createdName=Conan888, createdTime=Mon Jun 21 22:36:51 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947497, encodeId=34fe194e49767, content=<a href='/topic/show?id=c11f29e67e' target=_blank style='color:#2F92EE;'>#ATRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2976, encryptionId=c11f29e67e, topicName=ATRA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XhttJCp4Aq9gKA5n4v9elclQlVQTDenMiaEiadlI5D3gtmfSiaicoIY4ZsuibrQKLibDdxBKVY8oS6B2FicqJlT93clow/132, createdBy=03202500144, createdName=ms7258648636991762, createdTime=Fri Jan 01 23:46:50 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988036, encodeId=bfa81988036a2, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Sun Apr 11 02:46:50 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693235, encodeId=d8fa16932357e, content=<a href='/topic/show?id=523b585602f' target=_blank style='color:#2F92EE;'>#新疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58560, encryptionId=523b585602f, topicName=新疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e8329353204, createdName=gous, createdTime=Fri May 14 05:46:50 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908596, encodeId=c53f90859626, content=满足COVID-19疫苗运输、存储和处理所需的三种温度要求。目前看来这是个好消息。, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5008534db22c474a844fbd107ff83af2/d3e20fc133b542208ff15e7f2b575329.jpg, createdBy=c7015311102, createdName=Jessie Zhang, createdTime=Wed Dec 16 16:03:15 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908326, encodeId=6c4f908326ee, content=棒棒哒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46085442053, createdName=ms6000000716169829, createdTime=Tue Dec 15 22:00:50 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908303, encodeId=3988908303e9, content= 评论中加<a href='/topic/show?id=979f91e9623' target=_blank style='color:#2F92EE;'>#话题#</a>,可以多加<a href='/topic/show?id=4365e5104f1' target=_blank style='color:#2F92EE;'>#积分#</a>哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91796, encryptionId=979f91e9623, topicName=话题), TopicDto(id=75104, encryptionId=4365e5104f1, topicName=积分)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Tue Dec 15 21:23:01 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
    2021-05-14 gous
  6. [GetPortalCommentsPageByObjectIdResponse(id=1657389, encodeId=ce73165e389ed, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Mon Nov 29 09:46:50 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975604, encodeId=feef9e56043d, content=话题, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210621/63f11e7c9993487f87168975d59885d7/bb210ee9bc0940eb806cb237495a7430.jpg, createdBy=91575377355, createdName=Conan888, createdTime=Mon Jun 21 22:36:51 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947497, encodeId=34fe194e49767, content=<a href='/topic/show?id=c11f29e67e' target=_blank style='color:#2F92EE;'>#ATRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2976, encryptionId=c11f29e67e, topicName=ATRA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XhttJCp4Aq9gKA5n4v9elclQlVQTDenMiaEiadlI5D3gtmfSiaicoIY4ZsuibrQKLibDdxBKVY8oS6B2FicqJlT93clow/132, createdBy=03202500144, createdName=ms7258648636991762, createdTime=Fri Jan 01 23:46:50 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988036, encodeId=bfa81988036a2, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Sun Apr 11 02:46:50 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693235, encodeId=d8fa16932357e, content=<a href='/topic/show?id=523b585602f' target=_blank style='color:#2F92EE;'>#新疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58560, encryptionId=523b585602f, topicName=新疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e8329353204, createdName=gous, createdTime=Fri May 14 05:46:50 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908596, encodeId=c53f90859626, content=满足COVID-19疫苗运输、存储和处理所需的三种温度要求。目前看来这是个好消息。, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5008534db22c474a844fbd107ff83af2/d3e20fc133b542208ff15e7f2b575329.jpg, createdBy=c7015311102, createdName=Jessie Zhang, createdTime=Wed Dec 16 16:03:15 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908326, encodeId=6c4f908326ee, content=棒棒哒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46085442053, createdName=ms6000000716169829, createdTime=Tue Dec 15 22:00:50 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908303, encodeId=3988908303e9, content= 评论中加<a href='/topic/show?id=979f91e9623' target=_blank style='color:#2F92EE;'>#话题#</a>,可以多加<a href='/topic/show?id=4365e5104f1' target=_blank style='color:#2F92EE;'>#积分#</a>哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91796, encryptionId=979f91e9623, topicName=话题), TopicDto(id=75104, encryptionId=4365e5104f1, topicName=积分)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Tue Dec 15 21:23:01 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
    2020-12-16 Jessie Zhang

    满足COVID-19疫苗运输、存储和处理所需的三种温度要求。目前看来这是个好消息。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1657389, encodeId=ce73165e389ed, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Mon Nov 29 09:46:50 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975604, encodeId=feef9e56043d, content=话题, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210621/63f11e7c9993487f87168975d59885d7/bb210ee9bc0940eb806cb237495a7430.jpg, createdBy=91575377355, createdName=Conan888, createdTime=Mon Jun 21 22:36:51 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947497, encodeId=34fe194e49767, content=<a href='/topic/show?id=c11f29e67e' target=_blank style='color:#2F92EE;'>#ATRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2976, encryptionId=c11f29e67e, topicName=ATRA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XhttJCp4Aq9gKA5n4v9elclQlVQTDenMiaEiadlI5D3gtmfSiaicoIY4ZsuibrQKLibDdxBKVY8oS6B2FicqJlT93clow/132, createdBy=03202500144, createdName=ms7258648636991762, createdTime=Fri Jan 01 23:46:50 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988036, encodeId=bfa81988036a2, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Sun Apr 11 02:46:50 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693235, encodeId=d8fa16932357e, content=<a href='/topic/show?id=523b585602f' target=_blank style='color:#2F92EE;'>#新疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58560, encryptionId=523b585602f, topicName=新疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e8329353204, createdName=gous, createdTime=Fri May 14 05:46:50 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908596, encodeId=c53f90859626, content=满足COVID-19疫苗运输、存储和处理所需的三种温度要求。目前看来这是个好消息。, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5008534db22c474a844fbd107ff83af2/d3e20fc133b542208ff15e7f2b575329.jpg, createdBy=c7015311102, createdName=Jessie Zhang, createdTime=Wed Dec 16 16:03:15 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908326, encodeId=6c4f908326ee, content=棒棒哒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46085442053, createdName=ms6000000716169829, createdTime=Tue Dec 15 22:00:50 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908303, encodeId=3988908303e9, content= 评论中加<a href='/topic/show?id=979f91e9623' target=_blank style='color:#2F92EE;'>#话题#</a>,可以多加<a href='/topic/show?id=4365e5104f1' target=_blank style='color:#2F92EE;'>#积分#</a>哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91796, encryptionId=979f91e9623, topicName=话题), TopicDto(id=75104, encryptionId=4365e5104f1, topicName=积分)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Tue Dec 15 21:23:01 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
    2020-12-15 ms6000000716169829

    棒棒哒!

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1657389, encodeId=ce73165e389ed, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Mon Nov 29 09:46:50 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975604, encodeId=feef9e56043d, content=话题, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210621/63f11e7c9993487f87168975d59885d7/bb210ee9bc0940eb806cb237495a7430.jpg, createdBy=91575377355, createdName=Conan888, createdTime=Mon Jun 21 22:36:51 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947497, encodeId=34fe194e49767, content=<a href='/topic/show?id=c11f29e67e' target=_blank style='color:#2F92EE;'>#ATRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2976, encryptionId=c11f29e67e, topicName=ATRA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XhttJCp4Aq9gKA5n4v9elclQlVQTDenMiaEiadlI5D3gtmfSiaicoIY4ZsuibrQKLibDdxBKVY8oS6B2FicqJlT93clow/132, createdBy=03202500144, createdName=ms7258648636991762, createdTime=Fri Jan 01 23:46:50 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988036, encodeId=bfa81988036a2, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Sun Apr 11 02:46:50 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693235, encodeId=d8fa16932357e, content=<a href='/topic/show?id=523b585602f' target=_blank style='color:#2F92EE;'>#新疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58560, encryptionId=523b585602f, topicName=新疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e8329353204, createdName=gous, createdTime=Fri May 14 05:46:50 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908596, encodeId=c53f90859626, content=满足COVID-19疫苗运输、存储和处理所需的三种温度要求。目前看来这是个好消息。, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5008534db22c474a844fbd107ff83af2/d3e20fc133b542208ff15e7f2b575329.jpg, createdBy=c7015311102, createdName=Jessie Zhang, createdTime=Wed Dec 16 16:03:15 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908326, encodeId=6c4f908326ee, content=棒棒哒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46085442053, createdName=ms6000000716169829, createdTime=Tue Dec 15 22:00:50 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908303, encodeId=3988908303e9, content= 评论中加<a href='/topic/show?id=979f91e9623' target=_blank style='color:#2F92EE;'>#话题#</a>,可以多加<a href='/topic/show?id=4365e5104f1' target=_blank style='color:#2F92EE;'>#积分#</a>哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91796, encryptionId=979f91e9623, topicName=话题), TopicDto(id=75104, encryptionId=4365e5104f1, topicName=积分)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Tue Dec 15 21:23:01 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
    2020-12-15 lifefamily

    评论中加#话题#,可以多加#积分#

    0

相关资讯

Lancet:ChAdOx1 nCoV-19疫苗安全性及预防症状性新冠肺炎效果显著

ChAdOx1 nCoV-19疫苗可有效预防症状性COVID-19

NEJM:NVX-CoV2373疫苗表现出良好的安全性及免疫效果

NVX-CoV2373疫苗是安全的,其诱导接种者的免疫反应水平超过了Covid-19患者恢复期血清抗体水平,添加Matrix-M1佐剂后,诱导的CD4+T细胞反应偏向Th1表型

NEJM:辉瑞/BioNTech新冠mRNA疫苗有效率为95%!FDA将紧急应用授权

上周三,英国率先批准了辉瑞-BioNTech联合研发的新冠疫苗用于紧急用途,本周已在英国进行较大范围接种。当时有声音批评英国太着急了。事实上,英国是基于疫苗的III期临床试验结果而批准的。本周研究结果

外媒:美国辉瑞等疫苗受益于中国科学家对病毒全基因组测序

新冠肺炎疫情还在全球蔓延,抗击疫情需要全球携手应对,需要各国科研人员通力合作。英国《卫报》12月6日发文追溯了全球科学家从发现病毒结构到疫苗研究的最新进展,并认为中国疾病预防控制中心传染病所研究员、上

疫苗“争夺战”打响,英国批准辉瑞新冠疫苗

在美国和欧盟尚未作出决定之时,辉瑞和BioNTech研发的新冠疫苗,在英国迎来了首个获批紧急使用。

拓展阅读

接种217针新冠疫苗,身体会发生什么?柳叶刀:全球接种最多的“狂人”,免疫系统竟一切正常!

The Lancet Infectious Diseases:在整个过度接种的过程中,这位大爷(下文被称为HIM)没有报告任何与接种疫苗相关的副作用,62项常规临床化学指标均未出现异常。

厦门大学韩家淮院士团队:为什么新冠疫苗的保护时间如此之短?——有关 COVID-19 疫苗的现状及未来

在这篇研究热点中,厦门大学生命科学学院韩家淮团队分析相关数据,提出新冠疫苗保护率下降迅速与新冠病毒本身性质密切相关。

高福院士团队最新:动态清零结束后,长新冠的发生率近50%,疫苗或改变现状

Emerging Microbes & Infection随着接种疫苗的剂量增加,保护作用也会有所增强;其中,接种4-5针新冠疫苗,表现出最强的保护作用,高烧、寒战、腹泻以及一些中长期症状会显著减少。

冠疫苗接种后,乳房假体包膜挛缩预后

今天我们介绍一个病例,一名大约6个月前植入硅胶植入物的患者在注射第二剂辉瑞疫苗后,一侧乳房突然出现严重包膜挛缩。据作者所知,这是第一份这种类型的报告。

上海最近“阳”的人又多了?警惕诱发这种病!

最近这段时间,除了35℃+炙烤大地,上海曜影医院24小时应急门诊,每天都会遇到好几例“阳”:

上海交大李青峰/复旦张文宏合作《STTT》:I型神经纤维瘤病患者接种新冠疫苗后呈现高水平免疫反应

开展相关研究以评价NF1患者接种新冠疫苗的安全性和有效性,具有重要的临床和社会意义。